Majid Mokhtari, MD, FCCP
Associate Professor of Medicine
Pulmonary and Critical Care Medicine
Shahid Beheshti University of Medical Sciences
I completed my basic medical training at Sydney University and the University of NSW in Sydney, Australia, followed by Internal Medicine residency training at the above university medical centers and New York University Medical Center till 1998. My fellowship training in Pulmonary and Critical Care Medicine was at the Memorial Sloan-Kettering Cancer Center, Cornell-Weill Medical Center, and Columbia University in New York till July 2001. Since then, I am working as a faculty member (associate professor of medicine) in Internal Medicine, Pulmonary, and Critical Care Medicine at the Shahid Beheshti Medical University (S.B.M.U.), Tehran, Iran.
Since February 2002, I have designed and helped to implement the curricula for the critical care fellowship training and critical care nurse training programs, with the ministry of health in Iran. These two programs are running successfully throughout the country for the last 17 years.
My clinical activities, teaching, and research engagements have been with S.B.M.U. medical centers in Tehran, Iran dealing with the everyday care of the patients in internal medicine, pulmonary and critical care medicine disciplines, diverse aspects of resident and fellow training, research, and administrative work. In addition to my clinical engagements, since the COVID-19 pandemic, I have been appointed and actively engaged in different COVID-19 prevention, management, and vaccine committees through the ministry of health.
Some of the areas of my research interests and publications are as follows; small airways disease, COPD, bronchiolitis, toxic lung injuries, molecular biology of lung cancer, VTE, critical care education, and ethics, infection prevention and control, sepsis, ARDS, traumatic brain injury, and ICU nutrition. I have contributed to many projects related to the COVID-19 disease such as the role of chest radiation in CRS, outpatient, and early pharmaceutical management, interferon inpatient management, COVID-19 vaccine platforms performance in the outcome of critically ill ICU patients, and a large national vaccine trial. In addition, I have been collaborating with a team of genetics and basic science team exploring different areas of cell biology in cancer diagnosis and management.